A gain-of-function mutation in ATP6V0A4 drives primary distal renal tubular alkalosis with enhanced V-ATPase activity
The ATP6V0A4 gene encodes the a4 subunit of vacuolar H+-ATPase (V-ATPase), which mediates hydrogen ion transport across the membrane. Previous studies have suggested that mutations in ATP6V0A4 consistently result in a loss of function, impairing the hydrogen ion transport efficacy of V-ATPase and leading to distal renal tubular acidosis and sensorineural hearing loss. Here, we identified a 32-year-old male patient and his father, both of whom harbored a heterozygous ATP6V0A4 p.V512L mutation and exhibited hypochloremic metabolic alkalosis, acidic urine, and hypokalemia. Through a series of protein structural analyses and functional experiments, the V512L mutation was confirmed as a gain-of-function mutation in the ATP6V0A4 gene. V512-a4 increased a4 subunit expression abundance by enhancing V512L-a4 stability and reducing its degradation, which in turn potentiated the capacity of V-ATPase to acidify the tubular lumen, leading to acidic urine and metabolic alkalosis. Through mutant V512L-a4 subunit structure-based virtual and experimental screening, we identified F351 (C25H26FN3O2S), a small-molecule inhibitor specifically targeting the V512L-a4 mutant. In conclusion, we identified a gain-of-function mutation in the ATP6V0A4 gene, broadening its phenotypic and mutational spectrum, and we provide valuable insights into potential therapeutic approaches for diseases associated with ATP6V0A4 mutations.
Authors
- Hong Fan
- Jianlu Wei (ORCID: https://orcid.org/0000-0003-3166-5227)
- Chengkun Wang
- Ting-song Li
- Wanyi Wang (ORCID: https://orcid.org/0000-0001-9482-9968)
- Qianqian Wu (ORCID: https://orcid.org/0000-0002-8402-4055)
- Zhi-Yuan Wei (ORCID: https://orcid.org/0000-0002-0716-5145)
- Rong Zhou (ORCID: https://orcid.org/0000-0003-4018-381X)
- Wen Shi (ORCID: https://orcid.org/0000-0002-6624-2331)
- Jun Liao (ORCID: https://orcid.org/0000-0002-2017-5065)
- Jiayuan Sun (ORCID: https://orcid.org/0000-0003-3158-3256)
- Peng Sun (ORCID: https://orcid.org/0000-0003-4117-4165)
- Hui Cai (ORCID: https://orcid.org/0000-0002-8878-2697)
- Xiaoliang Zhang (ORCID: https://orcid.org/0000-0002-5731-3038)
- Xin‐Hua Li (ORCID: https://orcid.org/0000-0001-9485-029X)
- Bin Wang (ORCID: https://orcid.org/0000-0002-7166-0482)
- Yuan‐Han Yang (ORCID: https://orcid.org/0000-0002-1918-9021)
- Yilin Zhang (ORCID: https://orcid.org/0000-0001-5350-8279)
- Lu Huang (ORCID: https://orcid.org/0000-0002-0808-8698)
- Bi-Cheng Liu (ORCID: https://orcid.org/0000-0002-9220-0477)
- Junlan Yang
- Xiaoxu Wang (ORCID: https://orcid.org/0009-0005-3699-8460)
Institutions
- Emory University (US)
- Sun Yat-sen University (CN)
- China Pharmaceutical University (CN)
- Ministry of Education (RO)
- Zhongda Hospital Southeast University (CN)
- Third Affiliated Hospital of Sun Yat-sen University (CN)
- Children's Hospital of Chongqing Medical University (CN)
- Southeast University (CN)
- Nanjing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Journal of Clinical Investigation
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1172/jci188807
- Citations
- 4
- Primary Topic
- ATP Synthase and ATPases Research
- Type
- article
- Field-Weighted Citation Impact
- 3.22
Funders
- Jiangsu Commission of Health
- National Natural Science Foundation of China
- Government of Jiangsu Province
- Nanjing Medical University
- Southeast University
- Jiangsu Provincial Key Research and Development Program
- Changjiang Scholar Program of Chinese Ministry of Education
- National Key Research and Development Program of China